Kainos Curatives Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 04-12-2024
- Paid Up Capital ₹ 5.20 M
as on 04-12-2024
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -3.73%
(FY 2020)
- Profit 249.53%
(FY 2020)
- Ebitda 26.38%
(FY 2020)
- Net Worth 193.30%
(FY 2020)
- Total Assets 31.68%
(FY 2020)
About Kainos Curatives
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.20 M, as per Ministry of Corporate Affairs (MCA) records.
Ravuri Lakshmi and Mary Vannala serve as directors at the Company.
- CIN/LLPIN
U74999MH2016PTC281488
- Company No.
281488
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 May 2016
- Date of AGM
21 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kainos Curatives?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravuri Lakshmi  | Director | 23-May-2016 | Current |
| Mary Vannala | Director | 23-May-2016 | Current |
Financial Performance of Kainos Curatives.
Kainos Curatives Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 3.73% decrease. The company also saw a substantial improvement in profitability, with a 249.53% increase in profit. The company's net worth Soared by an impressive increase of 193.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kainos Curatives?
In 2019, Kainos Curatives had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kainos Curatives?
Kainos Curatives has a workforce of 39 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kainos Curatives, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kainos Curatives's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
